Mississippi Lawyers for Victims of Eye Damage & Vision Loss Caused
Patients with interstitial cystitis (IC), a chronic bladder condition that
causes painful inflammation and/or irritation, are often prescribed Elmiron®,
a blood thinner and bladder protectant, to ease their symptoms. Devastatingly,
Elmiron® has been found to cause pigmentary maculopathy, a degenerative
eye disorder that could lead to vision changes, vision loss, and blindness.
At Richard Schwartz & Associates Injury Lawyers, P.A., we believe patients
should never be put at such a life-changing risk without their knowledge.
If you were injured as a result of taking Elmiron®, we invite you
to call one of our award-winning attorneys. We have experience holding
negligent corporations accountable; we want to fight for your right to
compensation, as well as try to prevent others from being hurt in the same way.
Call our Mississippi Elmiron®
attorneys today at (601) 869-0696 or contact us online. Consultations are free of charge.
Get the Facts: Elmiron®’s History and Harmful Side Effects
Elmiron®, pentosan polysulfate sodium, can only be obtained through
a prescription from a medical professional. In the medical community,
it is thought to be an effective treatment for bladder conditions, as
it provides an extra coating of protection along the walls of the bladder.
It is taken orally in the form of a pill and was first approved for use
in 1996. In fact, it was initially thought to be so harmless that it was
common to be prescribed Elmiron® as one of the first routes of treatment for IC.
Unfortunately, this prescription drug is now believed to be the cause behind
some patients’ pigmentary maculopathy. For this reason, lawsuits
against Elmiron®’s manufacturer,
Janssen Pharmaceuticals, Inc., have flooded in. The reason? People are alleging that Janssen Pharmaceuticals,
Inc. — a division of
Johnson & Johnson — failed to warn patients of all of the dangers Elmiron® posed.
In fact, pigmentary maculopathy was not known to be an associated risk
of the drug until 2015 when six different patients taking Elmiron®
showed signs of this rare eye condition. These patients were all seen
at the Emory Eye Center in Atlanta by doctors who had yet to encounter
such a disorder. Both a
2018 study conducted by scientists and a
2019 study by the American Academy of Ophthalmology support the idea that Elmiron® causes maculopathy. Despite this, the
drug is still approved by the United States Food and Drug Administration (FDA).
Do I Qualify for an Elmiron® Case?
If you are taking, or were previously taking, Elmiron®
and are now experiencing one or more of the following signs of maculopathy,
you may have a case:
- Change of color of the retina
- Dark spots in the middle of your vision
- Distorted vision, such as straight lines appearing curvy
- Colors appear less vivid
- Trouble reading
- Trouble adjusting to dim lighting
- Blurred vision
- Night blindness
We Are Here for Patients Injured by Elmiron®
For over three decades, our lawyers at Richard Schwartz & Associates
have fought against negligence on behalf of injured individuals throughout
Mississippi. All it takes is one call to speak to a member of our legal
team recognized by the National Trial Lawyers, Super Lawyers®, and
the American Association for Justice.
We know how hard it can be to go through a life-altering injury that is
no fault of your own. That is why we value dependability, community, and
communication as the pillars of our legal practice. If you are seeking
honest, compassionate legal representation, Richard Schwartz & Associates
is the firm for you.
Call one of our firm’s Elmiron®
eye damage attorneys at (601) 869-0696 today. Richard Schwartz & Associates
has offices in Jackson, Tupelo, and Hattiesburg.